Changes to legislation, NHS reforms and how pharma can support healthcare going forward.
LATEST >
Cambridge scientists develop test to revolutionise prostate diagnosis
To revolutionise screening and diagnosis of prostate cancer, scientists in Cambridge have developed an advanced test designed to accelerate personalised treatment for patients.
The innovative...
State of the Nation: What does the data tell us about the NHS – and how Industry can engage?
Oli Hudson, NHS Insights Director with Wilmington Healthcare’s consultancy team, explores recent NHS figures to show what the service needs from pharma. The year 2023...
- Advertisement -
The Trust Equation: how to transform partnerships
Fiona Bride, Director of Market Access, Novartis Pharmaceuticals UK, examines how bold partnerships can help the NHS overcome the challenges it faces. The past two...
- Advertisement - 
- Advertisement -
NHS rolls out drug reported to be the most expensive in the world
The NHS has struck a deal for a revolutionary gene therapy treatment, reportedly the most expensive drug in the world, that will offer babies...
Triumphs and tribulations: a forecast for 2022
As we move into an uncertain 2022, Wilmington Healthcare’s Oli Hudson picks out three...
Personalised medication: Why dosage is so important
Rizvan Faruk Batha MPharm, PGDip GPP, IPresc, MRPharmS, Superintendent Pharmacist and Director of Operations...
New depression treatment options from NICE
"People with depression should make the choice on what treatment option is right for them, in discussion with their healthcare professional, NICE says in the new draft guidance."
